Ballwin, MO, United States of America

Darin E Jones


Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Darin E. Jones: A Pioneer in Anticoagulant Innovation**

Introduction

Darin E. Jones, based in Ballwin, MO, is a prolific inventor known for his impactful contributions to the field of anticoagulant therapy. With a remarkable portfolio of 14 patents, his work primarily focuses on compounds that play a crucial role in inhibiting the coagulation cascade, thus offering innovative solutions for the treatment and prevention of thrombotic conditions.

Latest Patents

Among Darin's latest innovations are two significant patents. The first patent, titled "Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade," details compounds designed to inhibit serine proteases involved in coagulation. This invention has promising implications for anticoagulant therapy targeting various thrombotic diseases, including coronary artery and cerebrovascular disorders.

His second notable patent, "Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade," describes compounds and their prodrugs that prevent and treat thrombotic conditions by selectively inhibiting certain proteases of the coagulation cascade. These advancements highlight his commitment to addressing serious health issues through innovative chemical solutions.

Career Highlights

Darin has built a solid career working with renowned companies such as Pharmacia Corporation and Warner-Lambert Company. His experience in these organizations provided him with a platform to develop and refine his inventions, leading to significant contributions to the pharmaceutical industry, particularly in the field of anticoagulant therapies.

Collaborations

Throughout his career, Darin has collaborated with distinguished colleagues, including Melvin L. Rueppel and Michael S. South. These partnerships have undoubtedly enhanced his research and development efforts, allowing for innovative breakthroughs in drug development and therapeutic applications.

Conclusion

Darin E. Jones represents an inspiring figure in the world of pharmaceuticals with a focus on improving health outcomes through innovative inventions. His dedication to developing selective inhibitors of the coagulation cascade showcases his ability to merge scientific research with practical applications. As advancements continue in anticoagulant therapies, Darin’s contributions will undoubtedly remain influential in shaping future medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…